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Curcumin is a chemical compound that has low solubility and bioavailability and, for these 
reasons, limited biological effectiveness. For improvement, the solubility needs to be increased by 
nanotechnology and nanoparticles, among others. Nanostructured Lipid Carrier (NLC) is a new drug 
delivery system that offers several advantages, including a significant increase in drug solubility and 
entrapment efficiency. This study aimed to formulate curcumin into curcumin-loaded NLC preparation 
and determine its characteristics, absorption efficiency, and drug loading. The formulation used 
evaporation and solvent diffusion methods with three different concentrations, namely 5%, 10%, and 
15%. Spectrophotometry and HPLC were employed to test the absorption efficiency and drug loading 
capacity.  The results showed that the curcumin-loaded NLC preparation containing 10% curcumin 
had stable characteristics and produced particles sized 17.4 nm with a polydispersity index of 0.574 
and zeta potential of -63.43 mV. Based on the spectrophotometry results, the entrapment efficiency 
was 93.212%, and the drug loading capacity was 0.708%. Meanwhile, the HPLC showed that the 
entrapment efficiency was 93.007%, and the drug loading capacity was 0.795%. 
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Curcumin is a chemical compound responsible for the yellow color in turmeric and has a broad 
therapeutic effect (Soni et al., 2011). It has several unfavorable properties such as low solubility and 
low bioavailability (Wang et al., 2009; Yang et al., 2007), and this combination negatively affects its 
biological effectiveness (Shaikh et al., 2009). Therefore, developing formulas to increase the 
bioavailability of this natural compound becomes necessary (Ajazudin, 2010). 
Nanotechnology and nanoparticles are two approaches known to enhance the poor 
biopharmaceutical properties of curcumin by increasing its aqueous solubility (Torchilin, 2009; 
Ruenraroengsak et al., 2010; Sultana et al., 2013). Nanostructured Lipid Carrier (NLC) is a drug 
delivery system with several benefits, which include increased solubility of less dissolvable drugs, 
physical stability, and efficiency entrapment, as well as reduced skin irritation and  ease of 
manufacture and improvement (Sanad et al., 2010; Kaur et al., 2015; Jain and Jain, 2010). 
Based on the description above, research on the entrapment efficiency and drug loading of the 
curcumin-loaded NLC formula becomes necessary. This study is expected to obtain a stable 
preparation, with improved %entrapment efficiency and drug loading. 
 
MATERIALS AND METHODS 
Materials 
The tools used in this study were batch heater, hotplate, magnetic stirrer, homogenizer (IKA 
Ultra-Turrax), 130-Watt ultrasonic processor 20 kHz (Cole-Parmer), particle size analyzer (Delsa 
Nano Beckman Coulter), UV-1700 UV/Vis spectrophotometer (Shimadzu), Fourier-Transform 
Infrared (FTIR) Spectrophotometer (Shimadzu), JEOL JEM 1400  transmission electron microscope 
for the High Performance Liquid Chromatography (Shimadzu LC-20AT(HPLC)), and glassware. 
The materials included curcumin (Merck), cholesterol (Merck), oleic acid (Sigma-Aldrich), Tween 
80 (Merck), distilled water, potassium bromide (Merck), ethanol (Merck), and acetone (Merck). 
 
Curcumin-loaded NLC formulation 
Curcumin-loaded NLC was created by evaporation and solvent diffusion in aqueous systems. 
The stages were as follows: 60 mg of a mixture of cholesterol and 15% oleic acid (AO) was 
dissolved in a mixture of acetone (3 mL) and ethanol (3 mL), then heated at 60
0
C. Curcumin was 
added to the lipid phase (drug/lipid 10%), and the heating temperature was maintained at 60
0
C. 
Meanwhile, the aqueous phase was prepared by mixing distilled water (60 mL) with tween 80 
(concentration of 1%) and heating this mixture at a temperature of 60
0
C. Immediately, the aqueous 
mixture was added to the lipid mixture, and then homogenized using the IKA Ultra-Turrax 
homogenizer at 800 rpm for 2 to 4 minutes. Then, the pre-emulsion mixture was screened using 
ultrasound for 20 minutes at an amplitude of 20%. Finally, the NLC disperse was cooled to room 
temperature (25
0
C) and stored at 4
0
C (Emami et al., 2012). 
 
Characterization of curcumin-loaded NLC 
Curcumin-loaded NLC was characterized by particle size, zeta potential, and polydispersity 
index using Delsa
TM
 Nano C (Beckman Coulter, Inc.). The structure and morphology of the final 
product were observed under the JEOL JEM 1400 transmission electron microscope at an 
accelerating voltage of 100 kV. 
 
Identification of curcumin-loaded NLC 
The curcumin compounds in curcumin-loaded NLC was identified by Fourier-Transform 
Infrared (FT-IR) Spectroscopy. Afterward, the FTIR spectrum of the liquid samples was analyzed by 
dripping the sample onto KBr powder, followed by drying and homogeneous grinding. The IR 
spectrum was checked at the wavenumbers of 400 to 4000 cm
-1
. 
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Absorption efficiency analysis 
The efficiency of curcumin-loaded NLC was determined by centrifugation at 12,000 rpm for 
60 minutes. The supernatant was decanted and then measured using a UV-Vis spectrophotometer 
at a wavelength of 423 nm and by High-Performance Liquid Chromatography (HPLC). As for the 
drug loading, it was analyzed from the curcumin content in the NLC using a spectrophotometer at 
a wavelength of 423 nm and by High-Performance Liquid Chromatography (HPLC), with 
acetonitrile and 2% acetic acid as the mobile phase. The absorption efficiency (% EE) and drug 
loading (% DL) were calculated using the following equations: 
 
%EE = ( ) x 100%.........................................(1) 
%DL = ( ) x 100%.........................................(2) 
 
A = The amount of curcumin added 
B = The amount of curcumin in the supernatant 
C = The amount of curcumin added (DL) 
D = The number of excipients added 
 
 
RESULTS AND DISCUSSION 
 The curcumin-loaded NLC was formulated by evaporation and solvent diffusion with several 
variations in curcumin’s concentration (active substance), i.e., 5% or 3 mg curcumin (Formula 1), 10% or 6 mg 




Figure1. The curcumin-loaded NLC formulated with 10% curcumin  
 
Cholesterol was used as a solid lipid because it can increase the drug-carrying system to 
specifically target cancer cells (Emami et al., 2012), while oleic acid was chosen as a liquid lipid 
because it can produce NLC with a higher entrapment efficiency than any drugs that do not contain 
oleic acid. Tween 80 was selected as an emulsifier because, if enriched with this surfactant, the 
resultant NLC has a high entrapment efficiency (Attama and Müller-Goymann 2008). The 
combination of homogenization and ultrasonication techniques has several advantages, including 
nanoparticle preparations with smaller particle size and the use of simple and effective equipment 
for a scale of a laboratory (Asawale et al., 2014). Formula 2 (10%) produced curcumin-loaded NLC 
with clear yellow color, no sediment, no foaming, and favorable homogeneity (Figure 1). 
Meanwhile, Formula 1 and 2, each using 5% and 15% curcumin, yielded yellow liquid containing 
sediment. The presence of this deposit in the final product shows that the small particles are not well 
dispersed; in other terms, the curcumin-loaded NLC prepared using Formula 1 (5%) and Formula 3 
(15%) cannot be used for further testing. 
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Figure 2. The PSA analysis results of the produced curcumin-loaded NLC 
 
Particle size is an essential characteristic of nanoparticles because it determines the stability of 
the nanoparticle system. Smaller particle size increases the surface area and, consequently, leads to 
high solubility, making the particles easier to be absorbed in the body (Awad et al., 2008). The 
diameter size of the produced curcumin-loaded NLC was 17.4 nm. It proves that the oleic acid 
content in NLC initiates nano lipid formation with smaller particle sizes. Similar results are reported 
in other studies (Hu et al. 2008; Agrawal et al., 2010; Tiwari and Pathak, 2011). 
The polydispersity index represents the distribution of nanoparticle in a dosage form. In this 
study, the polydispersity index started from 0.01 to 0.5-0.7 for monodispersed particles. Based on 
the results of the particle size analyzer (Figure 2), the polydispersity index of the curcumin-loaded 
NLC was 0.574. Monodisperse nanoparticles can improve the stability of the nanoparticle system 
because they show the size, shape, and weight of homogeneous particles. A higher polydispersity 




Figure 3. The zeta potential analysis of the curcumin-loaded NLC 
 
The results showed that the zeta potential of the prepared curcumin-loaded NLC was -63.43 
(mV). Zeta potential represents the aggregation of the preparation, i.e., a high zeta potential, both 
negative and positive, indicates a colloidal system that tends to be stable and can prevent particles 
from aggregating. In general, particles with a zeta potential higher (more positive) than +30 mV or 
lower (more negative) than -30 mV are considered stable (Rosli et al., 2015). 
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Figure 4. The morphological analysis results of curcumin-loaded NLC, as observed  
under a transmission electron microscope 
The morphology of the NLC particle was examined under a transmission electron microscope. 
Based on the observation results, the curcumin-loaded NLC particles were round with a smooth 
surface and no appearance of particle aggregation (Figure 4). This finding is consistent with 
Almoussalam (2015), which suggests that nanoparticles with lipids as carriers have a round 
structure with a smooth surface, regardless of the type of the lipid used. The size of the curcumin 
nanoparticles obtained was 68.18 nm, which is similar to the size of curcuminoid nanoparticles 
prepared in Mujib (2011), that is, 70.21 nm. These results prove that the oleic acid content in NLC 
forms nano lipids with smaller particle sizes. 
 
Figure 5. The identification results of compounds in curcumin-loaded NLC by 
FTIR (the blue curve is the NLC spectrum, and the red one is 
curcumin) 
 
The infrared spectra of pure curcumin and curcumin-loaded NLC were compared (Figure 5). 
Based on the observation results, the standard infrared spectrum for curcumin was as follows: 1628 
cm
-1
 (for C = C aromatic), 1427 cm
-1
 (for CC aromatic), 1602 cm
-1
 (for conjugated diene), 1509 cm
-1
 
(for C = C ketones), 3200-3508 cm
-1
 (for OH bonded to the aromatic group), 809 cm
-1
 and 855 cm
-1
 
(for substituted aromatic ring). Meanwhile, the infrared spectrum of the NLC sample did not have 
the main peaks of curcumin (1628, 1427, 1602, 1509, 3200-3508, 809-855 cm
-1
), but those of oleic 
acid were apparent, as marked by the wavenumbers of 1644 cm
-1
 (for C = C alkene) and 3309 cm
-1
 
(OH-carboxylic). The different spectra between the standard curcumin and curcumin-loaded NLC 
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Table I. The entrapment efficiency and drug loading of curcumin-loaded NLC, as measured 
using a UV-VIS Spectrophotometer 
% Entrapment Efficiency % Drug Loading 
93.212 % 0.708 % 
Entrapment efficiency determines how much percentage of the active substance is absorbed in 
the NLC compared to the total curcumin added. The absorbance values showed that the concentration 
of curcumin was absorbed, while the absorption efficiency of the curcumin-loaded NLC was 
identified using a linear equation of the standard curcumin curve. The absorption efficiency was 
93.212% (Table I). Such a high absorption efficiency is likely to increase drug release (Sonaje et al., 
2007). The drug loading was measured by dividing the amount of curcumin absorbed in the 
nanoparticle system by the total amount of solution. This calculation yielded a drug loading of 
0.708%. A nanoparticulate system ideally has a high loading capacity that can reduce the quantity of 
material used for drug delivery. 
 
Table II. The absorption efficiency and drug loading of curcumin-loaded NLC-, as measured by   
High-Performance Liquid Chromatography (HPLC) 
% Entrapment Efficiency % Drug Loading 
93.007% 0.795% 
 
 A drug delivery system must have a high loading capacity. Entrapment efficiency is generally 
expressed in percent of drug absorption. In this study, the entrapment efficiency was determined by 
centrifuging curcumin-loaded NLC samples and measuring the supernatant by HPLC. The results 
showed that the entrapment efficiency of curcumin-loaded NLC was 93.07%. This figure is close to 
100%, indicating that curcumin was entirely encapsulated by NLC. Severino et al. (2015) formulate 
NLC with 1% surfactant and produce 90% entrapment efficiency. The amount of curcumin absorbed 
in the nanoparticle system was divided by the total amount of solution to quantify loading capacity. 
This calculation result showed that the drug loading of the produced curcumin-loaded NLC was 
0.795%. An ideal nanoparticle system has a high loading capacity, and in this condition, the quantity 
of materials used for drug delivery can be reduced. 
 
CONCLUSION 
Curcumin-loaded NLC that is prepared with 10% curcumin has stable characteristics, a particle 
size of 17.4 nm, a polydispersity index of 0.574, and zeta potential of -63.43 mV. Morphologically, 
it is round in shape with a smooth surface. Based on the spectrophotometry results, this preparation 
has an entrapment efficiency of 93.212% and a drug loading capacity of 0.708%. Meanwhile, the 
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